Henriques Débora Pereira, Martins Regina Helena Garcia, Cataneo Antônio José Maria
Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery Department, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu Medical School, Unesp, São Paulo, Brazil.
Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery Department, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu Medical School, Unesp, São Paulo, Brazil.
J Voice. 2023 Feb 17. doi: 10.1016/j.jvoice.2023.01.020.
Injectable laryngoplasty with hydroxyapatite and hyaluronic acid is frequently used for the treatment of glottic incompetence. The effectiveness of these substances is controversial due to the heterogeneity of studies.
To evaluate the effectiveness of the treatment for glottic incompetence using hydroxyapatite and hyaluronic acid.
Systematic review and meta-analysis.
MEDLINE, PUBMED, LILACS, SCOPUS, EMBASE, Cochrane, clinicaltrials.gov, published and unpublished trials, Web of Science.
Studies that evaluated vocal fold function before and after 4-6 weeks and 6 months of hydroxyapatite and hyaluronic acid injection in adults with glottic incompetence.
studies with outcome, follow-up time or type of intervention outside the predetermined pattern or systematic review and meta-analysis.
Primary outcome - Maximum Phonation Time. Secondary outcomes - Voice Handicap Index (VHI)-30, Parameters G and B of GRBAS Scale. Outcomes were analyzed for mean differences with the corresponding 95% CI.
Six hundred forty-four studies identified, 12 included (5 CaHA; 6 HA; 1 HA and CaHA). After 4-6 weeks the mean difference were: MPT (+5.86), IDV (-39.32), G (-1.14), and B (-1.46). After 6 months: MPT (+5.97), IDV (-30.13), G (-1.33), and B (-1.33).
Studies comparing injectable drugs are small, as well as the number of patients in each one, making the isolated comparison of substances difficult.
There is an evidence that the injectable substances HA and CaHA are effective in the treatment of glottic incompetence, however, it is important that more studies are carried out comparing the two substances.
注射用羟基磷灰石和透明质酸进行喉成形术常用于治疗声门闭合不全。由于研究的异质性,这些物质的有效性存在争议。
评估使用羟基磷灰石和透明质酸治疗声门闭合不全的有效性。
系统评价和荟萃分析。
MEDLINE、PUBMED、LILACS、SCOPUS、EMBASE、Cochrane、clinicaltrials.gov、已发表和未发表的试验、科学引文索引。
评估声门闭合不全的成年患者在注射羟基磷灰石和透明质酸4 - 6周及6个月前后声带功能的研究。
结局、随访时间或干预类型超出预定模式的研究,或系统评价和荟萃分析。
主要结局——最长发声时间。次要结局——嗓音障碍指数(VHI)- 30、GRBAS量表的G和B参数。分析结局的平均差异及相应的95%置信区间。
共识别出644项研究,纳入12项(5项羟基磷灰石钙;6项透明质酸;1项透明质酸和羟基磷灰石钙)。4 - 6周后的平均差异为:最长发声时间(+5.86)、嗓音障碍指数(-39.32)、G(-1.14)和B(-1.46)。6个月后:最长发声时间(+5.97)、嗓音障碍指数(-30.13)、G(-1.33)和B(-1.33)。
比较注射用药物的研究规模较小,且每项研究中的患者数量也较少,使得难以对这些物质进行单独比较。
有证据表明注射用物质透明质酸和羟基磷灰石钙对治疗声门闭合不全有效,然而,开展更多比较这两种物质的研究很重要。